A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research

Brain Research

Volumn 1156, Issue 1, 2007, Pages 99-111

  Ray, Andrew P ^a   Darmani, Nissar A ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Brainstem; Cisplatin; Emesis; Medulla; Tachykinin; Vomiting

Indexed keywords

MYELIN; SUBSTANCE P;

ANIMAL TISSUE; AREA POSTREMA; ARTICLE; BRAIN MAPPING; BRAIN METABOLISM; BRAIN SIZE; BRAIN STEM; BRAIN STEM NUCLEUS; CEREBELLUM; COMPARATIVE ANATOMY; DORSAL RAPHE NUCLEUS; HIPPOCAMPUS; HISTOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEAST SHREW; NEUROANATOMY; NEUROSCIENCE; NISSL SUBSTANCE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PHYLOGENY; PRIORITY JOURNAL; SHREW; SOLITARY TRACT NUCLEUS; TRIGEMINAL NUCLEUS; VOMITING;

ANIMALS; ATLAS; BEHAVIOR, ANIMAL; BRAIN; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; RESEARCH DESIGN; SHREWS; STEREOTAXIC TECHNIQUES; SUBSTANCE P;

CRYPTOTIS PARVA; MAMMALIA; PRIMATES; RODENTIA;

EID: 34250356357     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.04.061     Document Type: Article

References (55)

1. Ahn M.J., Lee J.S., Lee K.H., Suh C., Choi S.S., and Kim S.H. A randomized double-blind trial of ondansetron alone versus in combination with dexamethasone versus in combination with dexamethasone and lorazepam in the prevention of emesis due to cisplatin-based chemotherapy. Am. J. Clin. Oncol. 17 (1994) 150-156
2. 3A receptors: probable involvement of an allosteric modulatory site. Br. J. Pharmacol. 137 (2002) 589-596
3. Blomqvist A., and Mackerlova L. Spinal projections to the parabrachial nucleus are substance P-immunoreactive. Neuroreport 6 (1995) 605-608
4. Boissonade F.M., Sharkey K.A., and Davison J.S. Fos expression in ferret dorsal vagal complex after peripheral emetic stimuli. Am. J. Physiol. 266 (1994) R1118-R1126
5. Bountra C., Gale J.D., Gardner C.J., Jordan C.C., Kilpatrick G.J., Twissell D.J., and Ward P. Towards understanding the aetiology and pathophysiology of the emetic reflex: novel approaches to antiemetic drugs. Oncology 53 Suppl 1 (1996) 102-109
6. Cahen R.L. On the mechanism of emesis induced by 5-hydroxytryptamine. Proc. Soc. Exp. Biol. Med. 116 (1964) 402-404
7. Catania K.C., Lyon D.C., Mock O.B., and Kaas J.H. Cortical organization in shrews: evidence from five species. J. Comp. Neurol. 410 (1999) 55-72
8. Commons K.G., and Valentino R.J. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J. Comp. Neurol. 447 (2002) 82-97
9. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., and Malave J.J. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br. J. Cancer 66 (1992) 198-203
10. 3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. J. Neural Transm. 105 (1998) 1143-1154
11. Darmani N.A. Methods evaluating cannabinoid and endocannabinoid effects on gastrointestinal functions. Methods Mol. Med. 123 (2006) 169-189
12. Darmani N.A., and Johnson J.C. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Eur. J. Pharmacol. 488 (2004) 201-212
13. 3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). J. Neural Transm. 106 (1999) 1045-1061
14. 1 receptor in Cryptotis parva. The 15th Annual Symposium on the Cannabinoids vol. P56 (2005), Clearwater Beach, Florida
15. Darmani N.A., McClanahan B.A., Trinh C., Petrosino S., Valenti M., and Di Marzo V. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. Neuropharmacology 49 (2005) 502-513
16. Deguchi K., Antalffy B.A., Twohill L.J., Chakraborty S., Glaze D.G., and Armstrong D.D. Substance P immunoreactivity in Rett syndrome. Pediatr. Neurol. 22 (2000) 259-266
17. DeVane C.L. Substance P: a new era, a new role. Pharmacotherapy 21 (2001) 1061-1069
18. Dong X.G., and Yu L.C. Alterations in the substance P-induced anti-nociception in the central nervous system of rats after morphine tolerance. Neurosci. Lett. 381 (2005) 47-50
19. Fukui H., Yamamoto M., Ando T., Sasaki S., and Sato S. Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis. Neuropharmacology 32 (1993) 959-968
20. Goldstein D.L., and Newland S. Water balance and kidney function in the least shrew (Cryptotis parva). Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 139 (2004) 71-76
21. Harrison T.A., Hoover D.B., and King M.S. Distinct regional distributions of NK1 and NK3 neurokinin receptor immunoreactivity in rat brainstem gustatory centers. Brain Res. Bull. 63 (2004) 7-17
22. Hawthorn J., Ostler K.J., and Andrews P.L. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cisplatin in the ferret. Q. J. Exp. Physiol. 73 (1988) 7-21
23. Hesketh P.J., Van Belle S., Aapro M., Tattersall F.D., Naylor R.J., Hargreaves R., Carides A.D., Evans J.K., and Horgan K.J. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur. J. Cancer 39 (2003) 1074-1080
24. Horn C.C., Ciucci M., and Chaudhury A. Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton. Neurosci. 132 (2007) 44-51
25. Ito H., Nishibayashi M., Kawabata K., Maeda S., Seki M., and Ebukuro S. Induction of Fos protein in neurons in the medulla oblongata after motion- and X-irradiation-induced emesis in musk shrews (Suncus murinus). Auton. Neurosci. 107 (2003) 1-8
26. Koga T., and Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci. Res. 14 (1992) 166-179
27. Kwiatkowska M., Parker L.A., Burton P., and Mechoulam R. A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) 174 (2004) 254-259
28. Kyrkanides S., Tallents R.H., Macher D.J., Olschowka J.A., and Stevens S.Y. Temporomandibular joint nociception: effects of capsaicin on substance P-like immunoreactivity in the rabbit brain stem. J. Orofac. Pain 16 (2002) 229-236
29. Ladic L.A., and Buchan A.M. Association of substance P and its receptor with efferent neurons projecting to the greater curvature of the rat stomach. J. Auton. Nerv. Syst. 58 (1996) 25-34
30. McRitchie D.A., and Töurk I. Distribution of substance P-like immunoreactive neurons and terminals throughout the nucleus of the solitary tract in the human brainstem. J. Comp. Neurol. 343 (1994) 83-101
31. Miller A.D., and Leslie R.A. The area postrema and vomiting. Front. Neuroendocrinol. 15 (1994) 301-320
32. Miller A.D., and Ruggiero D.A. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J. Neurosci. 14 (1994) 871-888
33. Mock O.B. The least shrew (Cryptotis parva) as a laboratory animal. Lab. Anim. Sci. 32 (1982) 177-179
34. Mock O.B., Casteel S.W., Darmani N.A., Shaddy J.H., Besch-Williford C., and Towns L.C. Anatomic and physiologic reference values in least shrews (Cryptotis parva). Comp. Med. 51 (2001) 534-537
35. Mock O.B., Casteel S.W., Darmani N.A., Shaddy J.H., Besch-Williford C., and Towns L.C. 1,3-Dinitrobenzene toxicity in the least shrew, Cryptotis parva. Environ. Toxicol. Chem. 24 (2005) 519-2525
36. 4-receptor antagonist, in Suncus murinus and ferrets. J. Pharmacol. Sci. 98 (2005) 396-403
37. Napier T.C., Mitrovic I., Churchill L., Klitenick M.A., Lu X.Y., and Kalivas P.W. Substance P in the ventral pallidum: projection from the ventral striatum, and electrophysiological and behavioral consequences of pallidal substance P. Neuroscience 69 (1995) 59-70
38. Paxinos, G., Watson, C., 1998. The Rat Brain in Stereotaxic Coordinates, 4th ed., vol. 4. Elsevier Academic Press, San Diego.
39. Read N.W., and Gwee K.A. The importance of 5-hydroxytryptamine receptors in the gut. Pharmacol. Ther. 62 (1994) 159-173
40. Remple M.S., Reed J.L., Stepniewska I., and Kaas J.H. Organization of frontoparietal cortex in the tree shrew (Tupaia belangeri): I. Architecture, microelectrode maps, and corticospinal connections. J. Comp. Neurol. 497 (2006) 133-154
41. Rubenstein E.B., Slusher B.S., Rojas C., and Navari R.M. New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations. Cancer J. 12 (2006) 341-347
42. Satake H., and Kawada T. Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors. Curr. Drug Targets 7 (2006) 963-974
43. Schicho R., Donnerer J., Liebmann I., and Lippe I.T. Nociceptive transmitter release in the dorsal spinal cord by capsaicin-sensitive fibers after noxious gastric stimulation. Brain Res. 1039 (2005) 108-115
44. Simoneau I.I., Hamza M.S., Mata H.P., Siegel E.M., Vanderah T.W., Porreca F., Makriyannis A., and Malan Jr. T.P. The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94 (2001) 882-887
45. Slotnick B.M., and Leonard C.M. A Stereotaxic Atlas of the Albino Mouse Forebrain (1975), DHEW Publication, Washington, D.C.
46. Stahl S.M. The ups and downs of novel antiemetic drugs: Part 1. Substance P, 5-HT, and the neuropharmacology of vomiting. J. Clin. Psychiatry 64 (2003) 498-499
47. Sutoo D., Yabe K., and Akiyama K. Quantitative imaging of substance P in the human brain using a brain mapping analyzer erratum appears in Neurosci Res 2000 Apr;36(4):339-40]. Neuroscience Research 35 (1999) 339-346
48. Tanihata S., Oda S., Kakuta S., and Uchiyama T. Antiemetic effect of a tachykinin NK1 receptor antagonist GR205171 on cisplatin-induced early and delayed emesis in the pigeon. Eur. J. Pharmacol 461 (2003) 197-206
49. Van Bockstaele E.J., Gracy K.N., and Pickel V.M. Dynorphin-immunoreactive neurons in the rat nucleus accumbens: ultrastructure and synaptic input from terminals containing substance P and/or dynorphin. J. Comp. Neurol. 351 (1995) 117-133
50. 1 receptors in the brainstem of the ferret. Gastroenterology 121 (2001) 767-774
51. 1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am. J. Physiol.: Gasterointest. Liver Physiol. 285 (2003) G566-G576
52. Williams R.W., and Herrup K. The control of neuron number. Annu. Rev. Neurosci. 11 (1988) 423-453
53. Wynne B., and Robertson D. Somatostatin and substance P-like immunoreactivity in the auditory brainstem of the adult rat. J. Chem. Neuroanat. 12 (1997) 259-266
54. 2)11]substance P. Neuroscience 94 (1999) 663-673
55. Yip J., and Chahl L.A. Localization of tachykinin receptors and fos-like immunoreactivity induced by substance P in guinea-pig brain. Clin. Exp. Pharmacol. Physiol. 27 (2000) 943-946